Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher J. Kirk currently holds 431,348 shares of Kezar Life Sciences, Inc. (KZR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Kirk has been a net buyer of KZR stock. They have purchased $147.9K and sold $0 worth of shares.
Christopher J. Kirk's most recent insider trade was on Jul 20, 2023, when they sold 48,950 shares at $0.90 per share.
Christopher J. Kirk serves as Executive at Kezar Life Sciences, Inc. (KZR). They have executed 5 insider transactions totaling $147.9K over their tenure at the company.
Christopher J. Kirk holds the position of Executive at Kezar Life Sciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Christopher J. Kirk has shown a buying trading pattern, with $147.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher J. Kirk was on Feb 4, 2020, when they purchased $100.0K worth of KZR shares. This transaction involved 38,461 shares at $2.60 per share.
Christopher J. Kirk currently owns 431,348 shares of Kezar Life Sciences, Inc. (KZR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher J. Kirk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher J. Kirk has 5 Form 4 filings on record as an insider at Kezar Life Sciences, Inc..
Set alerts for Christopher J. Kirk and 40,000+ other insiders.